Dr. Fabigs Studie bezüglich der Genvarianten bei MCS Patienten wurde nun im Volltext in der Medizinzeitung Environmental Health veröffentlicht.
Volltext:
http://www.ehjournal.net/content/6/1/6
Herzliche Grüsse
Silvia
A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes
Eckart Schnakenberg1 , Karl-Rainer Fabig2 , Martin Stanulla4 , Nils Strobl3 , Michael Lustig3 , Nathalie Fabig2 and Werner Schloot3
1Institute for Pharmacogenetic and Genetic Disposition, Ostpassage 7, D-30853 Langenhagen, Germany
2Clinical Practice for Toxicology and Environmental Medicine, Immenhoeven 19, D-22417 Hamburg, Germany
3Center for Human Genetics and Genetic Counselling, University of Bremen, Leobenerstr. ZHG, D-28359 Bremen, Germany
4Children's Hospital, Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany
Environmental Health 2007, 6:6
doi:10.1186/1476-069X-6-6